Ophthalmic Medical Device Firm Mile Medical Receives RMB 40 Million Investment from Aopek Vision via Private Placement of 8.53 Million Shares

Mocular Medical (832652) announced on the evening of March 1 that Autek China subscribed to 8.5262 million shares of Mocular Medical's private placement with RMB 40 million of its own funds. By subscribing, Autek China increased its shareholding in Mocular Medical. After the investment is completed, Autek China will hold 28% of Mocular Medical's equity. Through this private placement, Autek China increased its stake in HangZhou Mocular Medical Technology Inc. by 8.5262 million shares.

In this equity change, the disclosure obligor Autek China increased its holdings in Mocular Medical from 15.347 million shares to 23.87 million shares, raising its shareholding ratio from 20% to 28%. Before and after the equity change, the company's largest shareholder did not change, the controlling shareholder did not change, and the actual controller did not change.

According to Tongbi Finance, the main business of HangZhou Mocular Medical Technology Inc. includes ophthalmic big data cloud storage consultation services, medical information integration systems, and the research, development, production, sales, and service of ophthalmic digital equipment. The main products encompass ophthalmic medical device hardware and ophthalmic medical device software.

In the first three quarters of 2021, the company's total operating revenue was 62.84 million yuan, a year-on-year increase of 20.26%; the net profit attributable to the parent company was 13.16 million yuan, a year-on-year increase of 67.2%. Earnings per share were 0.17 yuan.

As of 2020, the company's top five customers collectively accounted for 37.6609 million yuan in sales, representing 43.75% of total revenue, with the largest customer contributing 14.9531 million yuan, or 17.37%. The top five suppliers accounted for 27.3635 million yuan in purchases, making up 38.79% of total procurement, with the largest supplier accounting for 9.165 million yuan, or 12.99%.

Tongbi Finance Tip: According to publicly available data, Mocular Medical (832652) reported operating revenue of 86,061,844 yuan in 2020, with a net profit attributable to parent company of 18,380,314 yuan, return on equity of 19.26%, and revenue growth rate of 36.67%. The current sponsoring broker is Caitong Securities, the trading method is block trading, and it belongs to the innovation layer.